期刊文献+

体外诱导骨髓间充质干细胞向心肌样细胞分化 被引量:2

In vitro induction of differentiation of bone marrow derived mesenchymal stem cells to cardiomyocytelike cells
原文传递
导出
摘要 目的 探讨生长因子在体外能否诱导大鼠骨髓来源的间充质干细胞(BM-MSC)向心肌样细胞分化,是否增强其旁分泌作用.方法 取4周龄雄性SD大鼠骨髓,贴壁法培养BM-MSC至第3代时,应用流式细胞仪检测其表面标志物CD29、CD44、CD105、CD34、CD45、CD31.将细胞随机分为间充质干细胞组(MSC组)和生长因子共培养组(GF-MSC组).MSC组继续培养传代;GF-MSC组与生长因子[其中包括培养基(IMDM)、2%胎牛血清(FBS)、20 nmol/L地塞米松、100μmo1/L维生素C(VitC)、50 μg/L成纤维细胞生长因子2(FGF-2)、10 μg/L成骨蛋白2(BMP-2)、2μg/L胰岛素样生长因子1(IGF-1)、青霉素和100 mg/L链霉素]共培养.1周后细胞免疫荧光染色检测两组细胞肌钙蛋白Ⅰ(TnⅠ)和结蛋白(Des)表达;反转录-聚合酶链反应(RT-PCR)检测两组细胞Tn Ⅰ和Des mRNA的表达;ELISA法检测两组细胞裂解液以及细胞培养上清中的肝细胞生长因子(HGF)和血管内皮生长因子(VEGF)的蛋白水平.结果 体外培养的BM-MSC表达CD29、CD44、CD105,而不表达CD31、CD34、CD45.免疫荧光染色显示GF-MSC阳性表达TnⅠ和Des.RT-PCR结果显示TnⅠ和Des mRNA在GF-MSC有阳性表达,而MSC为阴性表达.GF-MSC组HGF、VEGF在细胞裂解液和细胞培养上清中的蛋白水平(ng/L)高于MSC组(HGF裂解液32.05±0.41比12.10±0.21,培养上清574.21±4.19比169.16±2.41;VEGF裂解液45.66±2.22比30.37±0.54,培养上清487.78±36.29比44.25±1.31;均P<0.05).结论 体外与生长因子共培养,可诱导BM-MSC向心肌样细胞分化,并增强其旁分泌作用. Objective To investigate whether growth factors in vitro can induce rat bone marrow derived mesenchymal stem cells (BM-MSCs) differentiation to cardiomyocyte like cells,and enhance paracrine effect of BM-MSC.Methods The MSCs were isolated from the marrow of femur of 4-weeks old male SD rats and cultured.Cell surface markers(CD29,CD44,CD105,CD34,CD45,CD31) of BM-MSCs of the third passage were analyzed by flow cytometry.Cells were randomly divided into MSCs group and GF-MSCs group.MSCs group was cultured normally while GF-MSCs group was co-cultured with growth factors,including medium (IMDM),2% fetal bovine serum (FBS),20 nmol/L dexamethasone,100 μmol/L vitamin C (VitC),50 μg/L fibroblast growth factor-2 (FGF-2),10 μg/L osteogenic protein 2 (BMP-2),2 μg/Linsulin-like growth factor 1 (IGF-1),penicillin,and 100 mg/L streptomycin.After 1 week culture,protein expressions of troponin Ⅰ (Tn Ⅰ) and desmin (Des) were detected in both groups by immunofluorescence staining.Tn Ⅰ and Des mRNA expressions were detected by reverse transcription-polymerase chain reaction (RT-PCR).Release of hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) in cell lysates and cell culture supernatants from both groups was measured by ELISA assay.Results Cultured BM-MSCs expressed CD105,CD44,CD29,but not CD31,CD34 and CD45.GF-MSCs group showed positive expression of cardiac Tn Ⅰ and Des by immunofluorescence assay and RT-PCR,while MSCs group showed negative.Protein concentration levels (ng/L) of HGF and VEGF in cell lysates and cell culture supernatant were significantly higher in GF-MSCs group compared to MSCs group (HGF lysates:32.05±0.41 vs 12.10±0.21,cell culture supernatant 574.21±4.19 vs 169.16±2.41 ; VEGF lysates:45.66±2.22 vs 30.37± 0.54,cell culture supernatant 487.78±36.29 vs 44.25±1.31,all P<0.05).Conclusion Co-culture of BMMSCs with growth-factors in vitro can induce to cardiomyocyte like cell differentiation and enhances the paracrine effect of MSCs.
出处 《中华生物医学工程杂志》 CAS 2014年第1期1-6,共6页 Chinese Journal of Biomedical Engineering
关键词 间质干细胞 骨髓 肌细胞 心脏 细胞分化 Mesenchymal stem cells Bone marrow Myocytes, cardiac Cell differentiation
  • 相关文献

参考文献15

  • 1Phinney DG,Prockop DJ.Concise review:mesenchymal stem/multipotent stomal cells:the state of transdifferentiation and modes of tissue repair-current views[J].Stem Cells,2007,25:2896-2902.
  • 2Choi YH,Kurtz A,Stamm C.Mesenchymal stem cells for cardiac cell therapy[J].Hun Gene Ther,2011,22:3-17.
  • 3Bartunek J,Croissant JD,Wijns W,et al,Pretreatment of adult bone marrow mesenchymal stenlcells with cardiomyogenic growth factors and repair of the chronically infracted myocardium[J].Am J Physiol Heart Circ Physiol,2007,292:H1095-1104.
  • 4Rose RA,Jiang H,Wang X,et al.Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers,retain the stromal phenotype,and do not become functional cardiomyocyte in vitro[J].Stem Cells,2008,26:2884-2892.
  • 5Nakajima H,Sakakibara Y,Tambara K,et al.Delivery route in bone marrow cell transplantation should be optimized according to the etiology of heart diseases[J].Circ J,2008,72:1528-1535.
  • 6Boyle AJ,McNiece IK,Hare JM.Mesenchymal stem cell therapy for cardiac repair[J].Methods Mol Biol,2010,660:65-84.
  • 7Arminan A,Gandia C,Garcia-Verdugo JM,et al.Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction[J].J Am Coll Cardiol,2010,55:2244-2253.
  • 8Ohnishi S,Yanagawa B,Tanaka K,et al.Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis[J].J Moll Cell Cardiol,2007,42:88-97.
  • 9Toma C,Pittenger MF,Cahill KS,et al.Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart[J].Circulation,2002,105:93-98.
  • 10Crisan M,Yap S,Casteilla L,et al.A perivascular origin for mescnchymal stem cells in multiple human organs[J].Cell Stem Cell,2008,3:301-313.

同被引文献32

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部